Locally aggressive tumor development occurred at NCSC-MYCN injection sites within 120 days (average engraftment rate of 67%, average engraftment time of 114 days, 10/15 mice total), while no tumors formed at normal NCSC injection sites (Fig. 4a). This evidence concerns the gene MYCN and neoplasm.